DVN(DVN)
DVN
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|---|
| Revenue Avg | $23.24B | $26.39B | $27.07B | $27.39B | $27.34B |
| Low | $21.16B | $24.14B | $23.30B | $24.31B | $24.26B |
| High | $26.40B | $31.62B | $31.06B | $31.64B | $31.58B |
| EBITDA Avg | $11.08B | $12.58B | $12.90B | $13.05B | $13.03B |
| Low | $10.09B | $11.51B | $11.11B | $11.59B | $11.57B |
| High | $12.59B | $15.07B | $14.81B | $15.08B | $15.05B |
| EBIT Avg | $7.02B | $7.97B | $8.17B | $8.27B | $8.26B |
| Low | $6.39B | $7.29B | $7.04B | $7.34B | $7.33B |
| High | $7.97B | $9.55B | $9.38B | $9.55B | $9.54B |
| Net Income Avg | $3.21B | $3.42B | $3.96B | $3.76B | $2.95B |
| Low | $2.74B | $2.69B | $3.06B | $3.21B | $2.52B |
| High | $3.67B | $4.15B | $4.87B | $4.52B | $3.55B |
| EPS Avg | $5.06 | $5.35 | $6.10 | $5.97 | $4.69 |
| Low | $4.36 | $4.28 | $4.86 | $5.10 | $4.00 |
| High | $5.83 | $6.60 | $7.74 | $7.18 | $5.64 |
| Analysts (Rev / EPS) | 5 / 11 | 6 / 12 | 4 / 7 | 2 / 2 | 2 / 4 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 | Q2 2028 |
|---|---|---|---|---|---|---|---|---|
| Revenue Avg | $6.64B | $6.73B | $6.58B | $6.49B | $6.67B | $6.81B | $7.06B | $6.94B |
| Low | $5.88B | $5.93B | $5.59B | $5.51B | $5.66B | $5.79B | $6.00B | $5.89B |
| High | $7.60B | $7.80B | $7.61B | $7.51B | $7.71B | $7.88B | $8.16B | $8.02B |
| EBITDA Avg | $3.16B | $3.21B | $3.14B | $3.10B | $3.18B | $3.25B | $3.37B | $3.31B |
| Low | $2.80B | $2.82B | $2.66B | $2.63B | $2.70B | $2.76B | $2.86B | $2.81B |
| High | $3.62B | $3.72B | $3.63B | $3.58B | $3.67B | $3.76B | $3.89B | $3.82B |
| EBIT Avg | $2.00B | $2.03B | $1.99B | $1.96B | $2.01B | $2.06B | $2.13B | $2.10B |
| Low | $1.78B | $1.79B | $1.69B | $1.67B | $1.71B | $1.75B | $1.81B | $1.78B |
| High | $2.29B | $2.35B | $2.30B | $2.27B | $2.33B | $2.38B | $2.47B | $2.42B |
| Net Income Avg | $1.15B | $1.19B | $1.27B | $1.11B | $1.19B | $1.27B | $1.55B | $1.43B |
| Low | $799M | $933M | $1.02B | $889M | $958M | $1.02B | $1.25B | $1.15B |
| High | $1.49B | $1.45B | $1.53B | $1.33B | $1.43B | $1.53B | $1.86B | $1.72B |
| EPS Avg | $1.22 | $1.27 | $1.36 | $1.18 | $1.27 | $1.35 | $1.65 | $1.52 |
| Low | $0.85 | $0.99 | $1.09 | $0.95 | $1.02 | $1.09 | $1.33 | $1.23 |
| High | $1.59 | $1.54 | $1.63 | $1.41 | $1.53 | $1.62 | $1.98 | $1.83 |
| Analysts (Rev / EPS) | 6 / 13 | 6 / 13 | 3 / 5 | 3 / 5 | 3 / 5 | 3 / 5 | 4 / 6 | 4 / 6 |